Document is current
Any future updates will be listed below
-
Authors
Mason, Sophie L.
Junges, Leandro
Woldman, Wessel
Ftouni, Suzanne
Anderson, Clare
Terry, John R.
Bagshaw, Andrew P.
-
Funding
Funding for this research was provided by:
Engineering and Physical Sciences Research Council (EP/W035030/1, EP/J002909/1)
University of Birmingham, Alumni Scholarship
University of Birmingham, Open Access Fund
Waterloo Foundation (Ref no. 1970-4687)
University of Birmingham, Dynamic Investment Fund
Epilepsy Research UK (F2002)
Cooperative Research Centre for Alertness, Safety, and Productivity, Melbourne, Australia (1.1.01\_15)
Wellcome Trust (204846/Z/16/Z)
Biotechnology and Biological Sciences Research Council (BB/X013634/1)
- License Information
-
More Information
Article History
Received: 23 May 2024
Accepted: 4 November 2024
First Online: 14 November 2024
Declarations
:
: W.W and J.R.T are co-founders of Neuronostics Ltd. C.A reports no conflicts of interests related to the data or results reported in this paper. In the interest of full disclosure: C.A has received a research award/prize from Sanofi-Aventis; contract research support from VicRoads/Department of Transport Victoria, Rio Tinto Coal Australia, National Transport Commission, Tontine/Pacific Brands, Transport Accident Commission, Takeda Pharmaceutical; and lecturing fees from Brown Medical School/Rhode Island Hospital, Ausmed, Healthmed and TEVA Pharmaceuticals; and reimbursements for conference travel expenses from Philips Healthcare. In addition, she has served as a consultant through her institution to the Rail, Bus and Tram Union, the Transport Accident Commission and the National Transportation Committee. She has also served as an expert witness and/or consultant in relation to fatigue and drowsy driving. C.A was a Theme Leader in the Cooperative Research Centre for Alertness, Safety and Productivity. S.F reports no conflicts of interests related to the data or results reported in this paper. In the interest of full disclosure: S.F reports receiving consultancy fees from Circadian Therapeutics and AMO Pharma. All other authors declared that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
